Screening of congenital hypothyroidism in newborns in Bohemia and Moravia

O Hníková1, P Kracmar, Z Zelenka

  • 1Department of Pediatrics, Faculty Hospital in Praha, Czechoslovakia.

Endocrinologia Experimentalis
|June 1, 1989
PubMed

Insights

Congenital hypothyroidism screening in Czechoslovakia, using total thyroxine (T4) tests on newborns, identified an incidence of 1:5700. Early detection and treatment ensured normal development for affected infants.

Area of Science:

  • Endocrinology
  • Neonatal Health
  • Public Health Screening

Background:

  • Newborn thyroid function screening programs are crucial for early detection of congenital hypothyroidism.
  • Czechoslovakia initiated regional screening in 1975 and expanded to a national program in 1985.
  • The pilot study in 1981 assessed the incidence of congenital hypothyroidism across multiple centers.

Purpose of the Study:

  • To assess the incidence of congenital hypothyroidism in Czechoslovakian newborns.
  • To evaluate the effectiveness of total thyroxine (T4) screening methods.
  • To establish early treatment protocols for affected infants.

Main Methods:

  • Screening involved estimating total thyroxine (T4) from dried blood spots collected via heel prick on day five postpartum.
  • Initial screening utilized T4 estimation; later phases continued this method.
  • Data collected from 1985 to December 1987 included 313,618 newborn samples from Bohemia and Moravia.

Main Results:

  • The incidence of congenital hypothyroidism was determined to be 1:5059 in the pilot study and 1:5700 in the expanded national screening.
  • Early treatment, initiated before the first month of life, led to normal developmental outcomes.
  • An elevated incidence of altered thyroxine-binding globulin (TBG) production (1:6400) was observed, particularly in male infants.

Conclusions:

  • Newborn screening for congenital hypothyroidism is effective in identifying affected infants for timely intervention.
  • The implemented screening program successfully facilitated normal development in treated children.
  • The study highlights the importance of considering TBG variations in neonatal screening protocols.

Related Concept Videos